Abstract
PPD Biomarker Discovery Sciences provides a suite of biomarker services for pharma, biotech, academia, foundation and government clients. PPD Biomarkers is a leader in mass spectrometry-based analysis of proteins, peptides and metabolites, and in cytometry-based analysis of a few to hundreds of blood cell types. Together with other units of PPD, a global contract research organization, it is strategically positioned to support every stage of the biomarker pipeline. PPD can navigate the critical path from discovery profiling and qualification (clinical validation) to assay of validated markers in clinical trials for drug registration.
Financial & competing interests disclosure
H Schulman is an employee of PPD Biomarker Discovery Sciences. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.